Advanced search
Publication Cover
Neuro-Ophthalmology Volume 41, 2017 - Issue 5
Submit an article Journal homepage
169
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Medical Cannabis, a Beneficial High in Treatment of Blepharospasm? An Early Observation

Phillip M. RadkeDepartment of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, Minnesota, USAView further author information
,
Ali MokhtarzadehDepartment of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, Minnesota, USAView further author information
,
Michael S. LeeDepartment of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, Minnesota, USA;Department of Neurosurgery, University of Minnesota, Minneapolis, Minnesota, USA;Department of Neurology, University of Minnesota, Minneapolis, Minnesota, USAView further author information
&
Andrew R. HarrisonDepartment of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, Minnesota, USA;Department of Otolaryngology, University of Minnesota, Minneapolis, Minnesota, USACorrespondence[email protected]
View further author information
Pages 253-258 | Received 21 Feb 2017, Accepted 07 Apr 2017, Published online: 18 Jul 2017

References

  • Jankovic J, Kenney C. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neural Transm (Vienna) 2008;115:585–591.
  • Czyz CN, Burns JA, Petrie T, Watkins JR, Cahill KV, Foster JA. Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome. Am J Ophthalmol 2013;156:173–177.
  • Cossu G, Mereu A, Deriu M, Melis M, Molari A, Melis G, Minafra L, Pisano T, Cianchetti C, Ortu E, Sau G, Aiello I, Fresu M, Marrosu MG, Contu P. Prevalence of primary blepharospasm in Sardinia, Italy: a service-based survey. Mov Disord 2006;21:2005–2008.
  • Remier J, Gilg K, Karow A, Esser J, Franke GH. Health-related quality of life in blepharospasm or hemifacial spasm. Acta Neurol Scand 2005;111:64–70.
  • Jankovic J. Blepharospasm with basal ganglia lesions. Arch Neurol 1986;43:866–868
  • Ababneh OH, Cetinkaya A, Kulvin DR. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm. Clin Exp Ophthalmol 2014;42:254–261.
  • Corey-Bloom J, Wolfosn T, Gamst A, Jin S, Marcotte TD, Bentley H, Gouaux B. Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. CMAJ 2012;184:1143–1150.
  • Lakhan SE, Rowland M. Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review. BMC Neurol 2009;9:59.
  • Vaney C, Heinzel-Gutenbrunner M, Jobin P, Tschopp F, Gattlen B, Hagen U, Schnelle M, Reif M. Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study. Mult Scler 2005;10:417–424.
  • Zajicek JP, Sanders HP, Wright DE, Vickery PJ, Ingram WM, Reilly SM, Nunn AJ, Teare LJ, Fox PJ, Thompson AJ. Cannabinoids in Multiple Sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. J Neurol Neurosurg Psychiatry 2005;76:1664–1669.
  • Zajicek JP, Hobart JC, Slade A, Barnes D, Mattison PG, MUSEC Research Group. Multiple sclerosis and extract of cannabis: results of the MUSEC trial. J Neurol Neurosurg Psychiatry 2012;83:1125–1132.
  • Wade DT, Robson P, House H, Makela P, Aram J. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehabil 2003;17:21–29.
  • Wilsey B, Marcotte T, Deutsch R, Gouaux B, Sakai S, Donaghe H. Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain 2013;14:136–148.
  • Wilsey B, Marcotte T, Tsodikov A, Millman J, Bentley H, Gouaux B, Fishman S. A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. J Pain 2008;9:506–521.
  • Ellis RJ, Toperoff W, Vaida F, van den Brande G, Gonzales J, Gouaux B, Bentley H, Atkinson JH. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology 2009;34:672–680.
  • Wallace M, Schulteis G, Hampton Atkinson J, Wolfson T, Lazzaretto D, Bentley H, Gouaux B, Abramson I. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers. Anesthesiology 2007;107:785–796.
  • Duran M, Pérez E, Abanades S, Vidal X, Saura C, Majem M, Arriola E, Rabanal M, Pastor A, Farre M, Rams N, Laporte JR, Capella D. Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. Br J Clin Pharmacol 2010;70:656–663.
  • Koppel BS, Brust JC, Fife T, Bronstein J, Youssof S, Gronseth G, Gloss D. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders. Neurology 2014;82:1556–1563.
  • National Conference of State Legislatures. State medical marijuana laws. Available at: http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx. Accessed September 20, 2016.
  • Minnesota Department of Health. Medical cannabis qualifying conditions. Available at: http://www.health.state.mn.us/topics/cannabis/patients/conditions.html. Accessed September 20, 2016.
  • Office of National Drug Control Policy. Marijuana resource center: state laws related to marijuana. Available at: https://www.whitehouse.gov/ondcp/state-laws-related-to-marijuana. Accessed September 20, 2016.
  • Borgelt LM, Franson KL, Nussbaum AM, Wang GS. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy 2013;33:195–209.
  • Jankovic J, Kenney C, Grafe S, Goertelmeyer R, Comes G. Relationship between various clinical outcome assessments in patients with blepharospasm. Mov Disord 2009;24(3):407–413.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.